M Vitenet1, F Tubez2, A Marreiro3, G Polidori4, R Taiar5, F Legrand6, F C Boyer7. 1. Physical Medicine and Rehabilitation Department, Sébastopol Hospital, University of Reims Champagne-Ardenne, France; Physiotherapy Department, Robert Schuman University College, Libramont Chevigny, Belgium. 2. Physiotherapy Department, Robert Schuman University College, Libramont Chevigny, Belgium. 3. Cryotherapy Pole, Reims, France. 4. GRESPI, Research Group in Engineering Sciences, University of Reims Champagne-Ardenne, France. 5. GRESPI, Research Group in Engineering Sciences, University of Reims Champagne-Ardenne, France. Electronic address: redha.taiar@univ-reims.fr. 6. C2S, Cognition Health and Socialization, University of Reims Champagne-Ardenne, France. 7. Physical Medicine and Rehabilitation Department, Sébastopol Hospital, University of Reims Champagne-Ardenne, France.
Abstract
INTRODUCTION: Although fibromyalgia syndrome (SFM) affects 2-4 percent of adults, research has not identified a preferred therapeutic option for patients worldwide yet. Based on recent findings, it can be expected that whole body cryotherapy can improve health-reported quality of life by alleviating the symptoms of musculoskeletal pain and fatigue. OBJECTIVE: Our aim was to determine whether whole body cryotherapy only can result in improved perceived health and quality of life in fibromyalgia patients. METHODS:24 patients with fibromyalgia diagnosis were randomized into 2 groups (n=11 in the whole body cryotherapy group, n=13 in the control group). In the whole body cryotherapy group, 10 sessions of whole body cryotherapy were performed (in addition to usual care) in a standard cryotherapy room over a duration of 8days. Subjects in the control group did not change anything in their everyday activities. Quality of life was assessed just before and one month after treatment. RESULTS: Compared with the control group, patients in the whole body cryotherapy group reported significantly improved for health-reported quality of life. These effects lasted for at least one month following intervention. CONCLUSION: Based on these findings, whole body cryotherapy can be recommended as an effective clinically adjuvant approach in the improvement of health-related quality of life in fibromyalgia patients.
RCT Entities:
INTRODUCTION: Although fibromyalgia syndrome (SFM) affects 2-4 percent of adults, research has not identified a preferred therapeutic option for patients worldwide yet. Based on recent findings, it can be expected that whole body cryotherapy can improve health-reported quality of life by alleviating the symptoms of musculoskeletal pain and fatigue. OBJECTIVE: Our aim was to determine whether whole body cryotherapy only can result in improved perceived health and quality of life in fibromyalgiapatients. METHODS: 24 patients with fibromyalgia diagnosis were randomized into 2 groups (n=11 in the whole body cryotherapy group, n=13 in the control group). In the whole body cryotherapy group, 10 sessions of whole body cryotherapy were performed (in addition to usual care) in a standard cryotherapy room over a duration of 8days. Subjects in the control group did not change anything in their everyday activities. Quality of life was assessed just before and one month after treatment. RESULTS: Compared with the control group, patients in the whole body cryotherapy group reported significantly improved for health-reported quality of life. These effects lasted for at least one month following intervention. CONCLUSION: Based on these findings, whole body cryotherapy can be recommended as an effective clinically adjuvant approach in the improvement of health-related quality of life in fibromyalgiapatients.
Authors: Philipp Klemm; Johanna Becker; Iris Aykara; Thomas Asendorf; Gabriel Dischereit; Elena Neumann; Ulf Müller-Ladner; Uwe Lange Journal: Adv Rheumatol Date: 2021-01-13
Authors: Annika Döhmen; Milan Kock; Alexander Obbarius; Christoph Paul Klapproth; Felix Fischer; Matthias Rose Journal: Qual Life Res Date: 2022-10-01 Impact factor: 3.440
Authors: Giorgia Varallo; Paolo Piterà; Jacopo Maria Fontana; Michele Gobbi; Marco Arreghini; Emanuele Maria Giusti; Christian Franceschini; Giuseppe Plazzi; Gianluca Castelnuovo; Paolo Capodaglio Journal: J Clin Med Date: 2022-07-26 Impact factor: 4.964